Campaigners yesterday won a landmark victory in the fight to overturn a ban on Alzheimer’s drugs for tens of thousands of patients.
The Court of Appeal decided the process used by the Government’s rationing body to ban use of the drugs – which cost only £2.50 a day – was unfair.
The case, which was supported by a Daily Mail campaign, could pave the way for the drugs to be re-instated for newly diagnosed patients with ‘mild’ symptoms of the disease.
At present, Aricept, Exelon and Reminyl are restricted to those with moderate symptoms.
